Bibliography
- Hughes B. 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov 2008;5:107-9
- Who will develop the next generation of medications for mental illness? NIMH Directors Blog March 30, 2010. Available from: http://www.nimh.nih.gov/about/director/2010/ who-will-develop-the-next-generation- of-medications-for-mental-illness.shtml
- Cromelli D, Stolk P, Besancon L, Pharmaceutical Sciences in 2020. Nat Rev Drug Discov 2010;9:99-100
- Frantz S. How academia can help drug discovery. Nat Rev Drug Discov 2004;3:541
- Kozikowski AP, Roth B, Tropsha A. Why academic drug discovery makes sense. Science 2006;313:1235-6
- Lazo JS, Brady LS, Dingledine R. Building a pharmacological lexicon: small molecule discovery in academia. Mol Pharmacol 2007;72:1-7
- Frearson JA, Collie IT. HTS and hit finding in academia – from chemical genomics to drug discovery. Drug Discov Today 2009;14:1150-8
- Medicines for Malaria Venture – Joint Portfolios. Available from: http://www.mmv.org/article.php3?id_article=424&recherche=Broad%20Institute
- Drug discovery at Dundee Wellcome Trust News 2005. Available from: http://www.wellcome.ac.uk/News/ Media-office/Press-releases/2005/WTX027342.htm
- Hughes B. A Wellcome experiment in seeding drug discovery. Nat Rev Drug Discov 2010;9:178-80
- Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest 2006;116:2837-42
- Paul SM, Mytelka DS, Dunwiddie CT, How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;9:203-14
- Kimball TR, McCoy CE, Khoury PR, Obesity, diabetes damage young arteries, could shorten life. News release, AmericanHeart Association website (2009) [online]. Available from: http://americanheart.mediaroom.com/index.php?s=43&item=740)
- Gray NS. Drug discovery through industry-academic partnerships. Nat Chem Biol 2006;2:649-53
- Melese T, Lin SM, Chang JL, Cohen NH. Open innovation networks between academia and industry: an imperative for breakthrough therapies. Nat Med 2009;15:502-7
- Vallance P, Williams P, Dollery C. The future is much closer collaboration between the pharmaceutical industry and academic medical centers. Clin Pharmacol Ther 2010;87:525-7
- Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4:682-90
- Kaji K, Norrby K, Paca A, Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458:771-5
- Frearson JA, Brand S, McElroy SP, N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 2010;464:728-32
- De Clercq E. Highlights in the discovery of antiviral drugs: a personal retrospective. J Med Chem 2010;53:1438-50
- Kneller R. National origins of new drugs. Nat Biotechnol 2005;23:655-6
- Maxwell RA, Eckhardt SB. Drug Discovery: a Casebook and Analysis. Humana, Totowa, New Jersey; 1990
- Gilead Sciences and Royalty Pharma Announce $525 Million Agreement with Emory University to Purchase Royalty Interest for Emtricitabine. Gilead Sciences Press Release July 2005. Available from: http://www.gilead.com/pr_731707
- New Emory Institute for Drug Discovery Combines Research, Training, Global Partnerships News Release: Research, University News May 19, 2009. Available from: http://shared.web.emory.edu/emory/news/releases/2009/05/ emory-institute-for-drug-discovery.html
- Yale University To Expand Medical and Scientific Research Programs with Acquisition of Bayer Complex. Yale University Press Release June 2007. Available from: http://opa.yale.edu/news/article.aspx?id=1587
- U-M to buy Pfizer's former Ann Arbor property. University of Michigan Press Release January 2009. Available from: http://www.ur.umich.edu/0809/Dec15_08/29.php
- Woosley RL, Myers RT, Goodsaid F. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science. Clin Pharmacol Ther 2010;87:530-3
- Friend SH. The need for precompetitive integrative bionetwork disease model building. Clin Pharmacol Ther 2010;87:536-9
- MRC's Translational Research Strategy (2008) Available from: (http://www.mrc.ac.uk/consumption/groups/public/documents/content/mrc004551.pdf)
- NIH Roadmap for Medical Research. Available from: (http://nihroadmap.nih.gov/)
- Dundee collaboration to identify drug candidates to treat visceral leishmaniasis (2009) University of Dundee press release. Available from: http://www.dundee.ac.uk/pressreleases/2009/prjune09/candidates.htm
- Tralau-Stewart CJ, Wyatt CA, Kleyn DE, Drug discovery: new models for industry-academic partnerships. Drug Discov Today 2008;14(1/2):95-101
- News in Brief, News & Analysis Article. More pharma–academia R&D collaborations. Nat Rev Drug Discov 2010;9:259
- Hunter J, Stephens S. Is open innovation the way forward for big pharma? Nat Rev Drug Discov 2010;9:87-8
- The Lilly Phenotypic Initiative, Connecting compounds to patients. Available from: https://pd2.lilly.com/pd2Web
- Drug patent plan gets mixed reviews. Available from: http://www.nature.com/news/2009/090225/full/4571064a.html
- Gamo F-J, Sanz LM, Cristina de Cozar JV, Thousands of chemical starting points for antimalarial lead identification. Nature 2010;465:305-10
- Multi-Million Dollar Deal to Benefit Medical Research. The Scripps Research Institute Press Release October 2005. Available from: http://www.scripps.edu/news/press/102605.html
- Herrling PL. Financing R&D for neglected diseases. Nat Rev Drug Discov 2009;8:91